Context:

• Every day, oncology clinics across India face the same grim pattern. More than 70% of patients arrive with advanced-stage cancer, when treatment is complex, costly, and far less likely to cure.
• India has spent two decades building world-class cancer hospitals and advanced treatments. Yet these investments cannot deliver full benefit because most patients simply arrive too late.
• The answer lies upstream — in prevention and early detection, not just better treatment.
• This article highlights why India must shift its cancer strategy from a treatment-centric approach to one focused on prevention and early detection.
• It discusses the economic and health costs of late diagnosis, the importance of preventive education, emerging screening technologies, India-specific screening models, and the policy measures needed to improve cancer outcomes.

The Cost of Late Diagnosis

• Late diagnosis is not just a health issue — it is an economic one. Over three-quarters of cancer-affected households face catastrophic healthcare expenditure. This pushes families into poverty.
• Survival outcomes reveal the gap starkly. India's five-year survival rate for lung cancer is only about 4%, compared to nearly 33% in Japan.
• Similar gaps exist across other common cancers. This is not just about treatment quality — it reflects the stage at which patients enter the healthcare system.

Scale of the Burden

• India recorded an estimated 1.56 million new cancer cases and over 8.74 lakh cancer deaths in 2024.
• The lifetime risk of developing cancer stands at about 11% nationally, and exceeds 20% in some northeastern states.
• With an ageing population and changing lifestyles, this burden will only grow unless the national strategy changes.

Step One: Prevention as a Lifelong Priority

• Nearly half of all cancers are preventable. But awareness campaigns aimed at adults yield poor results, since lifestyle habits form early in life. Once habits are set, they are hard to reverse through awareness alone.
• Therefore, experts call for embedding "life skills" education in schools, on par with mathematics or social sciences.
• Such education should cover physical, mental, and social health, addictions, diet, vaccination, financial literacy, and civic responsibility — benefiting not just cancer prevention but also cardiac, neurological, and other chronic diseases.

Step Two: Enabling Earlier Diagnosis

• Public awareness that symptoms persisting beyond three weeks need medical evaluation can cut diagnostic delays.
• But symptom awareness alone is not enough — screening remains the most powerful tool to catch cancer before symptoms even appear.
• Organised screening in India has so far been limited mainly to cervical, breast, and prostate cancers. New scientific tools are expanding this scope.
• Multi-Cancer Early Detection (MCED) blood tests can potentially detect signals from ten or more cancers — including colorectal, lung, liver, pancreatic, ovarian, gastric, oesophageal, breast, prostate, and bladder cancers — through a single blood sample.
• These need careful validation for India before wider rollout.

A India-Specific Screening Model

• A single centralised screening programme cannot serve India's 1.4 billion people, given its geographic and socioeconomic diversity.
• Hence, analysts propose a layered model combining:
  • Community health workers
  • Digital risk assessment tools
  • Artificial Intelligence
  • Mobile diagnostic services
  • Strong referral pathways linking primary care to cancer centres
• Some foundations already exist. NITI Aayog is building a large imaging biobank with over 20,000 cancer patient profiles, which can help train AI tools to assist frontline workers in spotting suspicious lesions.

Policy Opportunity

• The Draft National Health Research Policy, 2026 offers a chance to accelerate this shift.
• By prioritising diseases with the highest health burden and pushing research with measurable impact, it signals a move from publication-driven research to implementation science — encouraging affordable screening technologies, risk-prediction models, and digital health platforms suited to India's diverse settings.

Conclusion

• True progress in cancer care isn't measured by advanced-stage treatment sophistication, but by how many cancers never reach that stage.
• It demands coordinated action among government, medical colleges, technology firms, and community health providers, placing prevention and early detection at the heart of India's cancer strategy.